Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder

Chun Yen Chen, Yi Wei Yeh, Shin Chang Kuo, Chih Sung Liang, Pei Shen Ho, Chang Chih Huang, Che Hung Yen, Jia Fwu Shyu, Ru Band Lu, San Yuan Huang

研究成果: Article同行評審

38 引文 斯高帕斯(Scopus)

摘要

Inflammatory processes play a crucial role in the pathophysiology of depression, and identifying the specific cytokines targeted by different antidepressants is important for personalized treatment. The aims of this study were to examine whether venlafaxine and paroxetine cause different immunomodulatory effects when used to treat patients with major depression and to clarify the relationships between plasma cytokine levels and the therapeutic effectiveness of these drugs. A total of 91 Han Chinese patients with major depression completed the 8-week paroxetine or venlafaxine treatment and 90 healthy controls were recruited. A multiplex assay was used to measure cytokines levels in patients with major depression before and after an 8-week venlafaxine and paroxetine treatment. Cytokine levels were measured in healthy controls at the baseline. The 21-item Hamilton Depression Rating Scale was used to assess the changes in psychopathological symptoms from the baseline to the end point in each patient. Venlafaxine treatment caused greater decreases in the levels of interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), interleukin 4 (IL-4), IL-5, IL-1β, and IL-8 than did paroxetine. Paroxetine treatment increased the levels of proinflammatory cytokines IFN-γ, TNF-α, and IL-6 and decreased Th2 cytokine levels. After paroxetine treatment, IL-6 levels increased more in the non-remitter group than in the remitter group. In the remitter group, IL-4 and IL-5 levels decreased to values seen in the healthy controls. After venlafaxine treatment in both the remitter and non-remitter groups, IL-1β levels decreased to values seen in the healthy controls. Our results suggest that venlafaxine and paroxetine have different immunomodulatory properties and that venlafaxine has greater anti-inflammatory effects than paroxetine.

原文English
頁(從 - 到)108-118
頁數11
期刊Psychoneuroendocrinology
87
DOIs
出版狀態Published - 2018 1月

All Science Journal Classification (ASJC) codes

  • 內分泌學、糖尿病和代謝
  • 內分泌
  • 內分泌和自主系統
  • 精神病學和心理健康
  • 生物精神病學

指紋

深入研究「Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder」主題。共同形成了獨特的指紋。

引用此